52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
UnitedHealth Group Reports Q4 Adjusted Earnings Per Share $3.90
OptumRx To Buy Diplomat's Outstanding Common Stock For $4 Per Share
UnitedHealth Sees 2020 Revenue From Health Insurance Business Between $208 Bln– $210 Bln
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to an array of customers and markets, and includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses. OptumInsight provides services, technology and healthcare solutions to participants in the healthcare industry. OptumRx provides retail network contracting, purchasing and clinical solutions.
9900 Bren Rd E
Stephen J. Hemsley
Executive Chairman of the Board
Andrew Philip Witty
Group President, Chief Executive Officer, Executive Vice President, Director
John F. Rex
Chief Financial Officer, Executive Vice President
Marianne D. Short
Executive Vice President, Chief Legal Officer
D. Ellen Wilson
Executive Vice President - Human Capital
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
UnitedHealth Group Inc, the largest U.S. health insurer, reported a better-than-expected fourth-quarter profit on Wednesday, and said it expects strong sales of its government health plans this year.
UnitedHealth Group Inc reported a 16.5% rise in fourth-quarter profit on Wednesday, helped by strength in its core business that sells health plans as well as its Optum segment, which includes its pharmacy benefits management unit.
Diplomat Pharmacy Inc <DPLO.N> on Monday agreed to UnitedHealth Group Inc's <UNH.N> over $300 million buyout offer, weeks after it warned of its inability to pay off some of its debt amid intense competition in the pharmacy benefits management business.
UnitedHealth Group Inc's pharmacy services unit, Optum, would buy Diplomat Pharmacy Inc, valuing the company at about $303 million.
Health insurer UnitedHealth Group <UNH.N> on Monday issued its adjusted earnings forecast for 2020, the midpoint of which was below analysts' estimates.
UnitedHealth Group Inc <UNH.N> on Tuesday provided an optimistic outlook for 2020 profit, saying it expected growth to be at least 13%, which outpaces current Wall Street estimates and sent its shares up as much as 8.6%.
U.S. stocks opened higher on Tuesday, as strong earnings reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson allayed concerns about the fallout from a prolonged U.S.-China trade war on corporate America.
UnitedHealth expects 2020 adjusted earnings growth in the low end of its long-term growth range of 13% to 16%, Chief Executive Officer Dave Wichmann said during a conference call, above the 11 percent rate of growth represented by the midpoint of current analyst consensus.
U.S. stock index futures rose on Tuesday, as the third-quarter earnings season got off to an upbeat start with robust reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson.
UnitedHealth Group Inc reported an 11% rise in third-quarter profit on Tuesday, helped by higher revenue in its core business that sells health plans, and strength in its Optum unit, which includes its pharmacy benefits management business.
UnitedHealth Group Inc <UNH.N> will stick with its decision to pass on drug maker discounts to patients to help them beat rising medicine prices despite the U.S. government having withdrawn a similar proposed policy in its health programs, its top executive said on Thursday.
UnitedHealth Group Inc <UNH.N> will stick to its plan to implement point-of-sale rebates to all its members, Chief Executive Officer David Wichmann said on Thursday.
UnitedHealth Group Inc will stick to its plan to implement point-of-sale rebates to all its members, Chief Executive Officer David Wichmann said on Thursday.
UnitedHealth Group Inc reported a 12.7% rise in second-quarter profit on Thursday, as the company added more members to its health plans and revenue climbed in its Optum unit, which includes its pharmacy benefit management business.
UnitedHealth Group Inc has agreed to buy healthcare payments firm Equian LLC from its private-equity owner New Mountain Capital for about $3.2 billion, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
UnitedHealth Group Inc has agreed to buy health-care payments firm Equian LLC from its private-equity owner New Mountain Capital for about $3.2 billion, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.
UnitedHealth Group Inc won antitrust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz Editing by Leslie Adler)
* UNITEDHEALTH EXECUTIVE ANDREW WITTY FLAGS "REAL RISK" OF PRICE INFLATION IF EFFECTIVE NEW SYSTEM TO REPLACE CURRENT REBATES IS NOT PUT IN PLACE- CONF. CALL
UnitedHealth Group Inc said on Tuesday it expects minimal impact to its margins if the rebate system is overhauled but investors remained concerned about the impact of the Trump administration's proposal to end discounts from drugmakers.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.